Hennie Geldenhuys

Also affiliated with South African Tuberculosis Vaccine Initiative

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response”.

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response

Scientific Reports(2020)10.1038/s41598-020-65043-8

N/A

0.774DataRank · unranked

173 citations

Stanley Kimbung Mbandi, Ethan Thompson, Simon C. Mendelsohn, Sara Suliman, Novel N. Chegou +92 more

Validation of a host blood transcriptomic biomarker for pulmonary tuberculosis in people living with HIV: a prospective diagnostic and prognostic accuracy study

The Lancet Global Health(2021)10.1016/s2214-109x(21)00045-0

N/A

0DataRank · unranked

51 citations

Andrew Fioré-Gartland, Adam Penn‐Nicholson, Humphrey Mulenga, Stanley Kimbung Mbandi, Bhavesh Borate +94 more

T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection

Nature Medicine(2023)10.1038/s41591-022-02110-9

N/A

0DataRank · unranked

100 citations

Huang Huang, Chunlin Wang, Qiong Xia, Virginie Rozot, Akshaya Krishnan +86 more

Live-attenuated Mycobacterium tuberculosis vaccine, MTBVAC, in adults with or without M tuberculosis sensitisation: a single-centre, phase 1b–2a, double-blind, dose-escalation, randomised controlled trial

The Lancet Global Health(2025)10.1016/s2214-109x(25)00046-4

N/A

0DataRank · unranked

17 citations

Virginie Rozot, Claire Imbratta, Frances Ratangee, Justin Shenje, Michèle Tameris +62 more

Safety, reactogenicity, and immunogenicity of MTBVAC in infants: a phase 2a randomised, double-blind, dose-defining trial in a TB endemic setting

EBioMedicine(2025)10.1016/j.ebiom.2025.105628

N/A

0DataRank · unranked

12 citations

Virginie Rozot, Claire Imbratta, Hennie Geldenhuys, Simon C. Mendelsohn, Angelique Kany Kany Luabeya +58 more